Search | Médecins Sans Frontières Access Campaign

2800 results found
There are 0 active filters

2800 results found

Herman gets tested for HIV in the PODI Ouest in Kinshasa, Democratic Republic of Congo. The PODIs, which are run by the RNOAC group of people with HIV, offer testing, support and Antiretroviral drugs (ARVs) to stable HIV patients in the capital.

Press release |

28 July 2022

Following WHO recommendation, access to new game-changing HIV prevention drug needs to be accelerated

At 2022 International AIDS Conference, MSF calls for increased access to long-acting cabotegravir (CAB-LA) for HIV prevention (PrEP).

Tags HIV/AIDS cabotegravir World Health OrganizationViiV

Infographic

Cabotegravir for PrEP

In 2020, around 1.5 million people were newly infected with HIV. Global targets endorsed at the World Health Assembly 2022 aim to reduce new HIV infections from 1.5 million to under 370,000 by 2025 and under 335,000 by 2030. In order ...

Tags HIV/AIDS HIV/AIDS cabotegravir

Issue brief |

25 July 2022

Cabotegravir: What are we waiting for?

Tags HIV/AIDS HIV/AIDS cabotegravir Medicines Patent PoolWorld Health Assembly

Trips WAIVER protest at MC12 event in Geneva, Switzerland

Newsletter |

24 July 2022

WTO adopts inadequate text, not a real Waiver on COVID monopolies

The struggle for fair access to medicines has been struck a terrible blow following the adoption by the World Trade Organization (WTO) last week of an inadequate text rather than the originally proposed “TRIPS Waiver” on COVID monopolies, championed by MSF, civil society and over 100 countries.

Letter |

19 July 2022

CSO letter to ViiV calling for access to HIV PrEP drug CAB-LA

CSO letter to ViiV on access to HIV PrEP drug cabotegravir

Tags HIV/AIDS HIV/AIDS

Jérôme Tognotti, MSF nurse supervisor, holding a vial of COVID vaccine used by teams to vaccinate homeless and migrant people

Press release |

24 June 2022

MSF responds to BioNTech announcement that it will set up first “BioNTainers” by end of 2022

MSF reiterates call for BioNTech to urgently transfer mRNA vaccine technology to WHO mRNA technology transfer hub in South Africa as well as manufacturers in low- and middle-income countries, as faster option.

Tags COVID-19 coronavirus mRNA

Press release |

23 June 2022

MSF warns that reduced funding for Neglected Tropical Diseases could be devastating

MSF reiterates its commitment to diagnosing and treating life-threatening NTDs in humanitarian settings as it signs the Kigali Declaration

Tags Tropical & neglected diseases nomaChagas diseasesleeping sicknesssnakebitevisceral leishmaniasis (kala azar) World Health Organization Rwanda

Blog |

22 June 2022

Starting over? A critical moment in the struggle against neglected tropical diseases

As COVID retreats — for the moment at least — in many places around the world, a space is opening up for urgent attention to be given once more to other global health challenges.

Press release |

17 June 2022

Inability to agree a real pandemic intellectual property Waiver at WTO is a devastating global failure for people the world over

MSF is disappointed in the inadequate outcome after nearly two years of discussions at the WTO  

Tags COVID-19 coronavirus TRIPS WTO

Letter |

15 June 2022

Open CSO letter to WTO Trade Ministers: Do not accept the current draft, demand a real Waiver

Civil society letter to Trade Ministers at the World Trade Organization (WTO) on real TRIPS Waiver

Tags COVID-19 TRIPS WTO

Press release |

15 June 2022

Trade Ministers at WTO should not accept current draft of Ministerial Decision on TRIPS

The People's Vaccine Alliance, Oxfam, Section27 of South Africa, MSF, and more than 150 CSOs called on Trade Ministers at the WTO not to accept the current draft of the Ministerial Decision on the TRIPS Agreement and demand a real ...

Tags COVID-19 coronavirus OxfamWTO

Press release |

11 June 2022

Draft decision text at WTO not even close to the real TRIPS Waiver

Governments negotiating at the WTO must stand strong against problematic draft decision text at ministerial conference and work to agree on a real Waiver

Tags COVID-19 TRIPS WTO

07 June 2022

#MC12: Which side of history will you be on?

At MC12, governments have a historic opportunity to choose lives over profits.

TRIPS protest supporting Access Campaign "No Patents, No Monopolies in a Pandemic" in Bogotá, Colombia.

Press release |

06 June 2022

MSF to governments negotiating at WTO: get it right and adopt the real TRIPS Waiver

To effectively increase people’s access to all COVID medical tools, governments must return to TRIPS Waiver proposed over 20 months ago

Tags COVID-19 coronavirus TRIPS WTO

MSF nurse Maryuri Garcia Valladares administers a COVID-19 vaccine to a Venezuelan migrant at the MSF health post in Aguas Verdes, close to the Peru-Ecuador border.

Press release |

31 May 2022

German government must push BioNTech to urgently transfer mRNA vaccine technology

On the eve of BioNTech’s annual shareholder meeting, where the German pharmaceutical corporation is expected to report billions of euros in profits from COVID vaccine sales, MSF urged the German government, which supported BioNTech’s ...

Tags COVID-19 coronavirus mRNA

Letter |

31 May 2022

Joint UK CSO letter to the UK government on TRIPS waiver negotiations and flawed CSO consultation process

UK civil society letter to UK government on TRIPS Waiver

Tags COVID-19 coronavirus WTO United Kingdom

Infographic

Hypertension

Cardiovascular disease is the world’s biggest killer, representing 32% of all global deaths. Of these deaths, 85% are due to heart attack and stroke. 1.13 billion people have hypertension, also known as high blood pressure, a condition ...

Tags Cardiovascular diseases

Report |

24 May 2022

Under Pressure: Strategies to improve access to antihypertensive medicines

This report by Resolve to Save Lives and MSF discusses access to hypertension medicines in low- and middle-income countries, and makes recommendations to reduce hypertension prevalence globally

Tags Cardiovascular diseases hypertension

Glucometer, syringes and test strips for patients with diabetes

Press release |

23 May 2022

Towards insulin for all: Operationalising the WHA74 resolution on diabetes

Recommendations to countries and the WHO to ensure that treatment options are accessible and affordable for people living with diabetes.

Tags Diabetes Diabetes Insulin WHO Executive BoardWorld Health AssemblyWorld Health Organization

Events |

22 May 2022

MSF at the 75th World Health Assembly

MSF activities at the 75th session of the World Health Assembly (WHA), May 22 - 28, 2022.

Tags World Health Assembly

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

Following WHO recommendation, access to new game-changing HIV prevention drug needs to be accelerated

Cabotegravir for PrEP

Cabotegravir: What are we waiting for?

WTO adopts inadequate text, not a real Waiver on COVID monopolies

CSO letter to ViiV calling for access to HIV PrEP drug CAB-LA

MSF responds to BioNTech announcement that it will set up first “BioNTainers” by end of 2022

MSF warns that reduced funding for Neglected Tropical Diseases could be devastating

Starting over? A critical moment in the struggle against neglected tropical diseases

Inability to agree a real pandemic intellectual property Waiver at WTO is a devastating global failure for people the world over

Open CSO letter to WTO Trade Ministers: Do not accept the current draft, demand a real Waiver

Trade Ministers at WTO should not accept current draft of Ministerial Decision on TRIPS

Draft decision text at WTO not even close to the real TRIPS Waiver

#MC12: Which side of history will you be on?

MSF to governments negotiating at WTO: get it right and adopt the real TRIPS Waiver

German government must push BioNTech to urgently transfer mRNA vaccine technology

Joint UK CSO letter to the UK government on TRIPS waiver negotiations and flawed CSO consultation process

Hypertension

Under Pressure: Strategies to improve access to antihypertensive medicines

Towards insulin for all: Operationalising the WHA74 resolution on diabetes

MSF at the 75th World Health Assembly